Dr. Jiaqi Lou, Ningbo No.2 Hospital, China
Lou Jiaqi, born on May 16, 1995, is a dedicated burn surgeon and researcher specializing in intestinal mucosal healing post-burn injury. He holds a Masterās degree in Burns/Surgery from Xuzhou Medical University (2019-2022) and a Bachelor’s degree in Clinical Medicine from Wenzhou Medical University Renji College (2013-2018). Currently, he serves as a Resident at Ningbo No.2 Hospitalās Department of Burns. His research focuses on circular and long non-coding RNAs in burn-induced intestinal damage, nutritional strategies for burn patients, and predictive modeling in burn care. With multiple publications in high-impact journals like Cell Death & Disease, Burns & Trauma, and Frontiers in Immunology, he has significantly contributed to advancing burn treatment methodologies. Proficient in molecular biology and bioinformatics, he actively integrates clinical practice with translational research, enhancing patient outcomes. His expertise extends to animal models, clinical nutrition, and machine learning applications in burn medicine.
Publication Profile
Scopus
Orcid
Education šš
Lou Jiaqi pursued his Bachelorās degree in Clinical Medicine at Wenzhou Medical University Renji College (2013-2018), where he gained a solid foundation in medical sciences and clinical practice. Following this, he completed his Masterās degree in Burns/Surgery at Xuzhou Medical University (2019-2022), focusing on post-burn intestinal mucosal healing and advanced molecular techniques. His postgraduate research centered on exploring the role of circular RNAs and long non-coding RNAs in burn-induced intestinal injury, utilizing qRT-PCR, bioinformatics analysis, and adenoviral transfection techniques. He also conducted extensive studies on enteral and parenteral nutrition strategies for burn patients, integrating randomized controlled trials and systematic reviews. Throughout his academic journey, he actively engaged in laboratory and clinical research, refining his expertise in molecular biology, protein interactions, and animal modeling. His strong academic background, combined with hands-on research and clinical exposure, has shaped him into a proficient clinician-scientist in burn medicine.
Experience š„
Lou Jiaqi is a Resident at the Department of Burns, Ningbo No.2 Hospital (2022-present), where he manages burn patient care and conducts translational research. Previously, he served as a Resident at The Affiliated Huaihai Hospital of Xuzhou Medical University and The 71st Group Army Hospital of PLA (2019-2022), gaining extensive experience in burn surgery and post-burn recovery. His clinical training began with rotations at leading hospitals, including Minhang Hospital and The First Affiliated Hospital of Wenzhou Medical University (2016-2018). During his early medical career, he interned at Ningbo No.1 Hospitalās Burn Department, refining his hands-on patient care and surgical skills. His experience spans acute burn management, surgical interventions, intensive care, and nutritional strategies for burn patients. Alongside his clinical duties, he integrates machine learning and predictive modeling to enhance patient outcomes, positioning himself at the forefront of innovative burn treatment methodologies.
Awards & Honors ššļø
Lou Jiaqi has received several accolades for his contributions to burn medicine and research. He was awarded the Certificate of Resident Standardization Training of China (2024), recognizing his advanced clinical expertise. His achievements in molecular biology and burn research have been acknowledged through multiple journal publications, including in Cell Biology International, Cell Death & Disease, and Burns & Trauma. He obtained the Medical Practitioners Qualification of China (2021) and the Basic Life Support Provider Certification (2022), demonstrating his commitment to patient safety and professional excellence. His studies on burn-induced intestinal injury and nutritional optimization in burn patients have earned him recognition in both national and international medical communities. With a strong research background, he has contributed to advancements in RNA-based therapies and predictive modeling, enhancing patient outcomes. His extensive training, combined with a passion for innovation, has solidified his reputation as a promising burn surgeon and scientist.
Research Focus š¬š§¬
Lou Jiaqi specializes in burn-induced intestinal mucosal healing, investigating the role of circular and long non-coding RNAs in post-burn intestinal injury. His research includes circRNA-mediated signaling pathways, ceRNA network modeling, and RNA-binding protein interactions to enhance tissue repair mechanisms. He has explored enteral and parenteral nutritional strategies to optimize burn patient recovery, conducting randomized controlled trials and systematic reviews. His expertise extends to molecular and cellular techniques such as qRT-PCR, Western blotting, ELISA, and dual-luciferase assays. Additionally, he applies machine learning and Mendelian randomization in predictive modeling for burn patient outcomes. His studies have led to significant publications in Cell Death & Disease, Burns & Trauma, and Frontiers in Immunology. By integrating basic science, clinical practice, and bioinformatics, he contributes to innovative therapeutic approaches in burn care, focusing on translational medicine and personalized treatment strategies for severe burn patients.
Publication Top Notes
-
“A Bidirectional Mendelian-Randomization Analyses of Genetically Predicted Circulating Levels of Systemic Inflammatory Regulators with Risk of Sepsis” (2024) examines genetic predictors of systemic inflammation and their association with sepsis risk.
-
“Development, Reliability, and Validity of the Second-Modified Nutrition Risk Screening 2002” (2024) focuses on enhancing nutritional risk screening tools for clinical settings.
-
“The Efficacy and Safety of Negative Pressure Wound Therapy in Paediatric Burns: A Systematic Review and Meta-Analysis of Randomized Controlled Trials” (2024) evaluates the effectiveness of negative pressure wound therapy in treating pediatric burn patients.
-
“A Two-Step, Two-Sample Mendelian Randomization Analysis Investigating the Interplay Between Gut Microbiota, Immune Cells, and Melanoma Skin Cancer” (2024) investigates the relationship between gut microbiota, immune response, and melanoma development.
-
“A Retrospective Study Utilizing MIMIC-IV Database to Explore the Potential Association Between Triglyceride-Glucose Index and Mortality in Critically Ill Patients with Sepsis” (2024) explores the link between triglyceride-glucose index levels and mortality rates in septic patients.
-
“Effects of Virtual Reality on Analgesia in Wound Care and Physical Therapy for Burn Patients: A Systematic Review and Meta-Analysis” (2024) assesses the use of virtual reality for pain management in burn care.
-
“Development and Validation of a Nomogram to Predict Hypothermia in Adult Burn Patients During Escharectomy Under General Anesthesia” (2024) introduces a predictive tool for hypothermia during specific surgical procedures in burn patients.
-
“Efficacy of Probiotics or Synbiotics in Critically Ill Patients: A Systematic Review and Meta-Analysis” (2024) examines the benefits of probiotics or synbiotics in critically ill patients.
-
“Causal Relationship Between the Gut Microbiome and Basal Cell Carcinoma, Melanoma Skin Cancer, Ease of Skin Tanning: Evidence from Three Two-Sample Mendelian Randomisation Studies” (2024) explores the causal links between the gut microbiome and various skin conditions.
-
“PRP8-Induced CircMaml2 Facilitates the Healing of the Intestinal Mucosa via Recruiting PTBP1 and Regulating Sec62” (2022) investigates molecular mechanisms involved in intestinal mucosal healing.